Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 2, 2006, Pages 305-312

  Chertow, Glenn M ^a   Blumenthal, Samuel ^a   Turner, Stewart ^a   Roppolo, Michael ^a   Stern, Leonard ^a   Chi, Eric M ^a   Reed, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALPHA HYDROXYERGOCALCIFEROL; 1 ALPHA-HYDROXYERGOCALCIFEROL; BONE DENSITY CONSERVATION AGENT; CALCITRIOL; CALCIUM; CINACALCET; ERGOCALCIFEROL; NAPHTHALENE DERIVATIVE; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; CALCIUM; ERGOCALCIFEROLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PHOSPHATES; RENAL DIALYSIS;

EID: 33746207542     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00870805     Document Type: Article

References (0)